Q05315 (LEG10_HUMAN) Homo sapiens (Human)

Galectin-10 UniProtKBInterProSTRINGInteractive Modelling

142 aa; Sequence (Fasta)

Available Structures

35 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of galectin-10 in complex with the Fab fragment of a Charcot-Leyden crystal solubilizing … Heteromer
2-141
CA;PGE;
Assess
Structure of galectin-10 in complex with the Fab fragment of a Charcot-Leyden crystal solubilizing … Heteromer
2-139
Assess
X-ray structure of human galectin-10 in complex with L-fucosehomo-2-mer1-142
FUL;
Assess
X-ray structure of human galectin-10 in complex with D-mannosehomo-2-mer1-142
BMA;
Assess
X-ray structure of human galectin-10 in complex with D-N-acetylgalactosaminehomo-2-mer1-142
NGA;
Assess
Galectin-10/Charcot-Leyden crystal protein crystal structurehomo-2-mer2-142
GOL;
Assess
Galectin-10/Charcot-Leyden crystal protein crystal structurehomo-2-mer2-142
Assess
Galectin-10/Charcot-Leyden crystal protein variant Q74A crystal structurehomo-2-mer2-142
GOL;
Assess
Galectin-10/Charcot-Leyden crystal protein variant K73A crystal structurehomo-2-mer2-142
GOL;
Assess
Charcot-Leyden crystal protein/Galectin-10 variant E33Ahomo-2-mer2-142
Assess
Galectin-10/Charcot-Leyden crystal protein variant C57A crystal structurehomo-2-mer2-142
GOL;
Assess
CHARCOT-LEYDEN CRYSTAL PROTEINhomo-2-mer2-142
Assess
X-ray structure of human galectin-10 in complex with D-galactosehomo-2-mer2-142
GAL;
Assess
Charcot-Leyden crystal protein/Galectin-10 variant E33A with lactosehomo-2-mer2-142
BGC;
Assess
Charcot-Leyden crystal protein/Galectin-10 variant E33Qhomo-2-mer2-142
Assess
Galectin-10/Charcot-Leyden crystal protein variant W72A crystal structurehomo-2-mer2-142
GOL;
Assess
Galectin-10/Charcot-Leyden crystal protein variant Q75Ahomo-2-mer2-142
GOL;
Assess
X-ray structure of a non-autocrystallizing galectin-10 variant, Gal10-Tyr69Gluhomo-2-mer1-141
PGE;PG4;
Assess
X-ray structure determined from recombinant Charcot-Leyden crystalhomo-2-mer2-141
GOL;
Assess
Galectin-10 complexed with ribosehomo-2-mer3-142
RIP;
Assess
Charcot-Leyden crystal protein/Galectin-10 variant Y35Ahomo-2-mer2-141
Assess
X-ray structure of human galectin-10 in complex with D-arabinosehomo-2-mer1-140
64K;
Assess
Structure of galectin-10 in complex with the Fab fragment of a Charcot-Leyden crystal solubilizing …homo-2-mer1-140
PG4;
Assess
Galectin-10/Charcot-Leyden crystal protein variant N65A crystal structurehomo-2-mer2-141
GOL;
Assess
X-ray structure of human galectin-10 in complex with D-allosehomo-2-mer2-140
ALL;
Assess
Charcot-Leyden crystal protein/Galectin-10 variant E33Dhomo-2-mer2-139
Assess
Galectin-10/Charcot-Leyden crystal protein-C29A crystal structurehomo-2-mer2-139
GOL;
Assess
Galectin-10/Charcot-Leyden crystal protein variant H53A crystal structurehomo-2-mer2-139
Assess
Galectin-10 variant H53A soaked in glycerol for 5 minuteshomo-2-mer2-139
GOL;
Assess
X-ray structure of human galectin-10 in complex with D-glucosehomo-2-mer3-140
BGC;
Assess
X-ray structure determined from ex vivo Charcot-Leyden crystalhomo-2-mer2-138
GOL;
Assess
CHARCOT-LEYDEN CRYSTAL PROTEIN - MANNOSE COMPLEXmonomer2-142
MAN;
Assess
CHARCOT-LEYDEN CRYSTAL PROTEIN/N-ETHYLMALEIMIDE COMPLEXmonomer2-142
NEQ;
Assess
Charcot-Leyden crystal protein/Galectin-10 variant W127Amonomer2-142
Assess
Charcot-Leyden Crystal Protein - pCMBS Complexmonomer2-140
PMB;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6a1v.1.Bhomo-2-mer0.932-142
99.30
Assess